Displaying drugs 14776 - 14800 of 14936 in total
2,2-bis(4-hydroxy-3-tert-butylphenyl)propane
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Viminol
Experimental
Cibenzoline
Experimental
Budipine
Experimental
Cloranolol
Experimental
Levomethadone
Experimental
Picloxydine
Experimental
Xibornol
Experimental
Clofibride
Experimental
Bisoxatin acetate
Experimental
Mosapramine
Experimental
Nelotanserin
Nelotanserin has been used in trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and REM Sleep Behavior Disorder. It is a highly selective antagonist at the 5-HT2A serotonin receptor. It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM...
Investigational
Matched Description: … trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and …
Indole Naphthyridinone
Experimental
6-Methylamino-5-Nitroisocytosine
Experimental
2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID
Experimental
NLX-P101
NLX-P101, gene therapy is developed by Neurologix to treat Parkinson’s disease. The gene is glutamic acid decarboxylase (GAD), whose product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and targets the subthalamic nucleus (STN), which is overactive in patients with Parkinson’s disease. NLX-P101 is being evaluated as...
Investigational
Matched Description: … product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and …
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID
Experimental
Displaying drugs 14776 - 14800 of 14936 in total